Thus, the degradation of pancreatic heparan sulfate proteoglycans (HSPGs) may be responsible for delivering the HS-containing species to the circulation in patients with mild AP (and, obviously, in individuals with severe AP). This evidence concerns the gene CD44 and alkaline phosphatase measurement.